BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...
BETHLEHEM, Pa., April 28 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. Dr. Lee joins ...
BETHLEHEM, Pa., Jan. 3, 2012 /PRNewswire/ — Particle Sciences, a leading drug delivery CRO, has added a third computational module to its DOSE™ program. The DOSE™ program uses a combination of ...
Precision medicine aims to transport therapeutic agents, such as molecules, proteins or RNA, to the exact place where they need to act within the body. One of the most promising strategies is the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results